Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer
Condition(s):Recurrent Liver CarcinomaLast Updated:September 12, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Recurrent Liver CarcinomaLast Updated:September 12, 2019Completed
Condition(s):Prostate CancerLast Updated:December 16, 2020Active, not recruiting
Condition(s):Prostate Cancer; TreatmentLast Updated:June 2, 2022Not yet recruiting
Condition(s):Refractory NeoplasmsLast Updated:July 4, 2016Unknown status
Condition(s):Metastatic Liver Cancer; Cholangiocarcinoma; Neoplasm MetastasisLast Updated:July 18, 2012Unknown status
Condition(s):Metastatic Colorectal CancerLast Updated:January 31, 2023Recruiting
Condition(s):Kidney CancerLast Updated:September 27, 2016Unknown status
Condition(s):Pancreas CancerLast Updated:November 18, 2023Recruiting
Condition(s):Pancreas Cancer, MetastaticLast Updated:March 9, 2022Active, not recruiting
Condition(s):Atrial FibrillationLast Updated:June 29, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.